Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial

Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer updates include Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link, with the prior Revision: v3.3.2 entry deleted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:31:14.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows a new revision label: Revision: v3.3.2, replacing the previous Revision: v3.2.0. This is a minor metadata update with no changes to the study details or user-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:39:42.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removal of the government funding lapse notice from the NCT01245816 study page on ClinicalTrials.gov.
    Difference
    0.4%
    Check dated 2025-11-17T17:17:56.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The new page shows minor UI tweaks and small textual edits to non-critical sections; core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T09:53:41.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Update to revision from v3.1.0 to v3.2.0 and add a government funding operating-status notice; remove a specific resource listing (Classic familial adenomatous polyposis).
    Difference
    5%
    Check dated 2025-10-05T14:31:27.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    - Added Revision: v3.1.0. - Removed several drug-safety/quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a possible scope reduction or reorganization in favor of the new version label.
    Difference
    0.5%
    Check dated 2025-09-28T09:48:40.000Z thumbnail image

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.